B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease Recurrence

Journal of Urology

Volumn 179, Issue 5, 2008, Pages 1954-1960

  Routh, Jonathan C ^a   Ashley, Richard A ^a   Sebo, Thomas J ^a   Lohse, Christine M ^a   Husmann, Douglas A ^a   Kramer, Stephen A ^a   Kwon, Eugene D ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

biological markers; kidney neoplasms; prognosis; T lymphocytes; Wilms tumor

Indexed keywords

ONCOPROTEIN; PROTEIN B7 H1; UNCLASSIFIED DRUG;

ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CHILD; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY NEOPLASMS; MALE; PROGNOSIS; RECURRENCE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 41749091806     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.01.056     Document Type: Article

References (16)

1. Green D.M., D'Angio G.J., Beckwith J.B., Breslow N.E., Grundy P.E., Ritchey M.L., et al. Wilms tumor. CA Cancer J Clin 46 (1996) 46
2. Pritchard-Jones K. Controversies and advances in the management of Wilms' tumour. Arch Dis Child 87 (2002) 241
3. Green D.M., Grigoriev Y.A., Nan B., Takashima J.R., Norkool P.A., D'Angio G.J., et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. J Clin Oncol 19 (2001) 1926
4. Green D.M., Breslow N.E., Beckwith J.B., Ritchey M.L., Shamberger R.C., Haase G.M., et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 19 (2001) 3719
5. Breslow N.E., Takashima J.R., Whitton J.A., Moksness J., D'Angio G.J., and Green D.M. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 13 (1995) 1851
6. Breslow N.E., Collins A.J., Ritchey M.L., Grigoriev Y.A., Peterson S.M., and Green D.M. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 174 (2005) 1972
7. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8 (2002) 793
8. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5 (1999) 1365
9. Thompson R.H., Gillett M.D., Cheville J.C., Lohse C.M., Dong H., Webster W.S., et al. Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A 101 (2004) 17174
10. Thompson R.H., Kuntz S.M., Leibovich B.C., Dong H., Lohse C.M., Webster W.S., et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res 66 (2006) 3381
11. Curiel T.J., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9 (2003) 562
12. Strome S.E., Dong H., Tamura H., Voss S.G., Flies D.B., Tamada K., et al. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 63 (2003) 6501
13. Hirano F., Kaneko K., Tamura H., Dong H., Wang S., Ichikawa M., et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 65 (2005) 1089
14. Thompson R.H., Webster W.S., Cheville J.C., Lohse C.M., Dong H., Leibovich B.C., et al. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma. Urology 66 suppl (2005) 10
15. Dong H., and Chen L. B7-H1 pathway and its role in the evasion of tumor immunity. J Mol Med 81 (2003) 281
16. Dome J.S., Cotton C.A., Perlman E.J., Breslow N.E., Kalapurakal J.A., Ritchey M.L., et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol 24 (2006) 2352